FXYD5 and hepatocellular carcinoma: Dysadherin has been implicated in promoting tumor aggressiveness by modulating the tumor microenvironment (TME) and epithelial plasticity in various solid tumors.14,32 In this study, we demonstrated that dysadherin also maintains CSC properties in HCC.